Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) vs ONAA 7J-TCU Manufacturing NOFO FY2026
Side-by-side comparison of two grants.
| Attribute | Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) | ONAA 7J-TCU Manufacturing NOFO FY2026 |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $5M |
| Deadline | Closes 2027-01-07 | Closes in 3 days |
| Region | US | US |
| Sector | Education | Education |
| Funder | National Institutes of Health | Small Business Administration |
| Who it's for | nonprofits, researchers, government | small-business, researchers, students, government |
noindex — no measured search demand